Breathing life into new markets
More and more, life sciences organizations are exploring the benefits of mergers and acquisitions. Whether they’re looking to grow their portfolio of existing products or want to expand operations to new markets overseas, a well-executed merger or acquisition can be a beneficial strategy for many organizations. But many M&A transactions are complex and multi-faceted, with the potential to create significant uncertainty in financial reporting. To navigate these issues, organizations need advisors with the experience and insight to help face the challenges – and opportunities – that come with M&A arrangements.
BDO provides guidance to pharmaceutical, biotech, and medical device manufacturers at every stage of development. From understanding the complexities of research and development tax credits and Health Canada and FDA regulations, to licensing agreements and due diligence, our professionals have the experience and insight necessary to navigate the world of life sciences.
Most importantly, BDO advises clients on how best to access capital, which is key to fuelling innovation, research, and development efforts. Our professionals also provide a holistic perspective, helping our clients structure their operations to be as tax-efficient as possible and identifying opportunities to drive additional value.